RxDoctor Payments Data

Rachel Liner

Psychiatric/Mental Health · Montgomery, ALNPI 1952878340

Payments from drug & device makers

$2,657in general payments, 2019–2025

Across 166 payments — averaging $16.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$987
  • Alkermes, Inc.$306
  • Takeda Pharmaceuticals U.S.A., Inc.$236
  • Otsuka America Pharmaceutical, Inc.$234
  • Lundbeck LLC$225
  • Axsome Therapeutics, Inc.$127
  • plus $542 from 9 others

What the payments were for

  • Food & beverage$2,657100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,657 in reported general payments places this provider in the 70th percentile of 378 psychiatric/mental health providers in Alabama.

See all psychiatric/mental health providers in Alabama

Medicare billing

Part B allowed, 2024
$9,261
Medicare patients
25
Services billed
120

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine15$209,073
RexultiBrexpiprazole14$19,352
Aripiprazole36$4,400
Lurasidone Hcl12$2,684
Atomoxetine Hcl17$2,504
Trazodone Hcl62$895
Lamotrigine56$810
Quetiapine Fumarate39$779
Escitalopram Oxalate39$709
Hydroxyzine Hcl45$675
Buspirone Hcl53$672
Duloxetine Hcl21$568
Mirtazapine15$381
Fluoxetine Hcl32$329
Venlafaxine Hcl ErVenlafaxine Hcl17$314

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$113$209,07315 claims
Otsuka America Pharmaceutical, Inc.Rexulti$234$19,35214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 378 psychiatric/mental health providers in Alabama.

Other psychiatric/mental health in Montgomery

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →